Ryan Saadi

Nessuna posizione attualmente

Patrimonio netto: 101 M $ in data 30/04/2024

59 anni

Health Technology

Profilo

Ryan Saadi is the founder of Tevogen Bio, Inc. and Tevogen Bio Holdings, Inc. He held the title of Chairman & Chief Executive Officer at both companies.
Tevogen Bio, Inc. was founded in 2020, while Tevogen Bio Holdings, Inc. was founded in 2024.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
71.95%	14/02/2024	118 443 975 ( 71.95% )	101 M $	30/04/2024

Posizioni attive di Ryan Saadi

Società	Posizione	Inizio

Tutte le posizioni attive di Ryan Saadi

Precedenti posizioni note di Ryan Saadi

Società	Posizione	Fine
Tevogen Bio, Inc. Tevogen Bio, Inc. BiotechnologyHealth Technology Tevogen Bio, Inc. is a late-stage biotech company based in Warren, NJ. Tevogen Bio is focused on developing accessible personalized immunotherapies using its pioneering technology, the exactcelltm platform, which produces scalable, rapidly available, unmodified allogeneic cytotoxic T lymphocytes (CTLs) for the treatment of cancers, viral infections, and the prevention of long-term complications of these conditions. Tevogen Bio's strategic partners share their values and mission, and their next-generation precision T cell platform is designed to provide increased specificity to eliminate malignant and virally infected cells while allowing healthy cells to remain intact. The company is committed to pioneering lifesaving innovations for viral diseases and cancers for which there is a high unmet need. The company was founded in 2020 by Ryan Saadi, who has been the CEO since then.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Ryan Saadi

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ryan Saadi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Tevogen Bio, Inc. Tevogen Bio, Inc. BiotechnologyHealth Technology Tevogen Bio, Inc. is a late-stage biotech company based in Warren, NJ. Tevogen Bio is focused on developing accessible personalized immunotherapies using its pioneering technology, the exactcelltm platform, which produces scalable, rapidly available, unmodified allogeneic cytotoxic T lymphocytes (CTLs) for the treatment of cancers, viral infections, and the prevention of long-term complications of these conditions. Tevogen Bio's strategic partners share their values and mission, and their next-generation precision T cell platform is designed to provide increased specificity to eliminate malignant and virally infected cells while allowing healthy cells to remain intact. The company is committed to pioneering lifesaving innovations for viral diseases and cancers for which there is a high unmet need. The company was founded in 2020 by Ryan Saadi, who has been the CEO since then.	Health Technology